Ozempic/Wegovy), a prescription medication primarily used for type 2 diabetes, and meal replacement shakes, a convenient dietary option
WADA placed semaglutide (Ozempic/Wegovy) on its Monitoring Program in 2024 , and from 1 January 2026 it added markers of tirzepatide (Mounjaro/Zepbound) too both now monitored in-competition and out-of-competition
Compounded formulations may not be recognised by name at international customs
That leads to reduced appetite, lower calorie intake, better blood-sugar control, and gradual, sustained weight loss
Suzuki K, Hatzikotoulas K, Southam L, Taylor HJ, Yin X, Lorenz KM, Mandla R, et al
Sections of 4 m thickness from the different groups were cut using a microtome, mounted on glass slides, and stained with hematoxylin and eosin (H&E) 69